Cardiomyocyte ultrastructural damage in β-thalassaemic mice

Chanita Sanyear1, Punnee Butthep, Ramaneeya Nithipongvanich

  • 1Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Salaya Campus, Phuttamonthon, Thailand.

Insights

This study evaluated heart pathology in mouse models of beta-thalassaemia. The R mouse model, exhibiting iron overload, showed progressive cardiac ultrastructural damage, making it suitable for studying thalassaemic heart disease.

Area of Science:

  • Cardiovascular Pathology
  • Hematology
  • Genetics

Background:

  • Beta-thalassaemia causes hereditary anemia due to reduced beta-globin production.
  • Cardiac complications from iron overload are the primary cause of mortality in beta-thalassaemia patients.

Purpose of the Study:

  • To evaluate cardiac pathology in various beta-thalassaemia mouse models using light and electron microscopy.
  • To identify a suitable animal model for in vivo studies of thalassaemic heart disease.

Main Methods:

  • Utilized thalassaemic mice with specific human beta-thalassaemia mutations (IVSII-654) and beta(E)-globin transgenes.
  • Employed light and electron microscopy to examine cardiac myocyte pathology.
  • Compared wild-type mice with genetically modified thalassaemic mouse models (654, E4, 654/E4, and R).

Main Results:

  • Iron deposition was observed in cardiac myocytes of 654 and R mice.
  • Ultrastructural cardiac damage, including mitochondrial swelling and myofilament loss, was evident exclusively in R mice.
  • Histopathological changes in R mice cardiomyocytes correlated with increased tissue iron levels.

Conclusions:

  • The R thalassaemic mouse model exhibits progressive cardiac ultrastructural pathology consistent with human thalassaemia.
  • This model is suitable for in vivo pathophysiological studies of the thalassaemic heart.
  • Findings highlight the critical role of iron overload in cardiac damage in beta-thalassaemia.

Related Concept Videos